Lygos creates microbial-based end-to-end manufacturing solutions at the cutting-edge juncture of biology and technology to provide market-transforming product opportunities. Lygos' first products -- malonic acid and derivatives -- replace low-quality petrochemical products produced at high economic and environmental cost in countries without strong environmental protection programs.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 12/13/16 | $13,000,000 | Series A |
Fifty Years First Round Capital IA Ventures OS Fund Vast Ventures Y Combinator | undisclosed |
| 07/19/18 | $15,500,000 | Series B |
First Round Capital IA Ventures OS Fund Y Combinator | undisclosed |
| 01/23/19 | $5,000,000 | Series B |
LG Technology Ventures | undisclosed |
